6 results
diabetes dm2 dosing management medications oral agonists classification comparison dmii hypoglycemics inhibitors inpatient mellitus pathophysiology renal rybelsus semaglutide table
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Medications • SGLT2i ... Meglitinides • GLP ... Receptor Agonists • DPP4i ... #Medications #pharmacology ... pathophysiology #endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
They work primarily ... a low risk of hypoglycemia ... very similar to DPP4s ... #Pharmacology #Dosing ... Diabetes #DM2 #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Increase Incretins (GLP-I ... inhibitors work ... minimal chance of hypoglycemia ... Renal #Dosing #Pharmacology ... Diabetes #DM2 #Endocrinology
Oral Hypoglycemics in Diabetes Management 1 INSULIN SENSITIZER • TZD -
Oral Hypoglycemics ... Prandase) • SGLT ... (Adlyxin) • DPP ... by inhibiting DPP ... Diabetes #Management #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
Otherwise, it works ... when compared to SGLT2 ... empagliflozin and DPP4 ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP ... -4 inhibitor, GLP ... receptor agonist, SGLT2i ... #Medications #pharmacology ... comparison #table #endocrinology
No results found for "MCL differential endocrinology workup pharmacology sglt2 hypoglycemia glp1 dpp4"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MCL #differential #endocrinology #workup #pharmacology #sglt2 #hypoglycemia #glp1 #dpp4